Literature DB >> 27334204

Rheumatoid arthritis: U-Act-Early finds tocilizumab favours RA remission.

Caroline Barranco.   

Abstract

Entities:  

Year:  2016        PMID： 27334204     DOI： 10.1038/nrrheum.2016.104

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.

Authors:  Johannes W J Bijlsma; Paco M J Welsing; Thasia G Woodworth; Leonie M Middelink; Attila Pethö-Schramm; Corrado Bernasconi; Michelle E A Borm; Cornelis H Wortel; Evert Jan Ter Borg; Z Nazira Jahangier; Willemijn H van der Laan; George A W Bruyn; Paul Baudoin; Siska Wijngaarden; Petra A J M Vos; Reinhard Bos; Mirian J F Starmans; Eduard N Griep; Joanna R M Griep-Wentink; Cornelia F Allaart; Anton H M Heurkens; Xavier M Teitsma; Janneke Tekstra; Anne Carien A Marijnissen; Floris P J Lafeber; Johannes W G Jacobs
Journal:  Lancet       Date:  2016-06-07       Impact factor: 79.321
  1 in total
  1 in total

1.  Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.

Authors:  Helene L Kammoun; Tamara Louise Allen; Darren Colin Henstridge; Michael James Kraakman; Lone Peijs; Stefan Rose-John; Mark Anthony Febbraio
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.